This inventor holds 6 USPTO granted patents. Top assignees: Orion Corporation, Other. Active years: 1999-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fin-23060 Turku, FI (1999)
- Turku, FI (2002 - 2009)
Company Filing History:
4 out of 189 
2 out of 834,453 Years Active: 1999-2009
Title: Antti Haapalinna: Innovator in Pharmaceutical Chemistry
Introduction
Antti Haapalinna is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that interact with alpha2-adrenoceptors. With a total of 6 patents to his name, Haapalinna's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents are "Polycyclic compounds as potent alpha2-adrenoceptor antagonists - A compound of formula I" and "Derivatives of quinoline as alpha-2 antagonists." These innovations highlight his focus on creating effective pharmaceutical agents that can potentially improve patient outcomes.
Career Highlights
Throughout his career, Antti Haapalinna has worked with Orion Corporation, a leading pharmaceutical company in Finland. His experience in this esteemed organization has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Haapalinna has collaborated with notable colleagues such as Jukka Sallinen and Arto J Karjalainen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Antti Haapalinna's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a significant inventor in the field. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile